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Oxidative stressCalpain 1 is an ubiquitous Ca2+-dependent cysteine protease. Although calpain 1 has been found in cardiac mi-
tochondria, the exact location within mitochondrial compartments and its function remain unclear. The aim of
the current review is to discuss the localization of calpain 1 in different mitochondrial compartments in relation-
ship to its function, especially in pathophysiological conditions. Brieﬂy, mitochondrial calpain 1 (mit-CPN1) is
located within the intermembrane space and mitochondrial matrix. Activation of the mit-CPN1 within inter-
membrane space cleaves apoptosis inducing factor (AIF), whereas the activatedmit-CPN1 within matrix cleaves
complex I subunits and metabolic enzymes. Inhibition of the mit-CPN1 could be a potential strategy to decrease
cardiac injury during ischemia–reperfusion.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Calpains are a family of calcium-dependent cysteine proteases [1].
The detailed structure of the calpain family can be found in recent excel-
lent reviews [2,3]. Calpains are divided into ubiquitous and tissue specif-
ic isoenzymes [1]. The ubiquitous calpains include calpain 1 (u-calpain),
calpain 2 (m-calpain), calpain 4 (a regulatory unit of calpains 1 and
2) [4,5], calpain 5, calpain 7, calpain 10, and calpain 14 [1–3]. The tissue
speciﬁc isoforms include calpain 3 (skeletal muscle), calpain 6 (stom-
ach), calpain 8 (smooth muscle), calpain 9 (stomach), calpain 11 (tes-
tes), calpain 12 (skin after birth), and calpain 13 (tests and lung)
[1–3]. Based on domain IV structure, calpains can also be deﬁned as
typical and atypical calpains [6]. The typical calpains (1, 2, 3, 8, 9, 11,
12, and 14) have a penta-EF hand in domain IV at their COOH-
terminus to bind with calcium, small regulatory units (calpain 4) [6,7],
and calpastatin (an endogenous inhibitor) [8,9], whereas the atypical
calpains (5, 6, 7, 10, and 13) lack the penta-EF hand [6] (Fig. 1). Calpains
are found in all cells of vertebrates and are implicated in pathophysio-
logical processes [1–3].
Calpains are traditionally considered as cytosolic proteins [1]. Acti-
vation of cytosolic calpains is involved in myocardial injury during
ischemia and reperfusion [3,10]. Ischemia–reperfusion increases cyto-
solic calpain 1 activity in isolated rabbit hearts [11,12] and calpain 2Division of Cardiology, VCU
nited States.activity in isolated rat hearts [13]. Activation of cytosolic calpains in-
creases cardiac injury during ischemia–reperfusion by cleaving full
length bid to truncated bid [11], Na+,K+-ATPase [14,15], Ca2+-ATPase
[16], α-fodrin [17], and troponin T [18].
Mitochondrial dysfunction plays a critical role in cardiac injury fol-
lowing ischemia–reperfusion [19–21] or during heart failure [22,23].
Recently, calpains have been localized within mitochondria [24–26].
The activity of mitochondrial localized calpain 1 is increased in the
mouse heart following ischemia–reperfusion [25]. This review will
focus on mitochondrial localized calpains and their role in cardiac
injury.
2. Localization of calpain within mitochondria
Calpains are known to be cytoplasmic enzymes [1], butwe and other
investigators have shown that calpains also exist within mitochondria
[24–26]. Calpain 1 is identiﬁed within mitochondria and involved in
cleavage of apoptosis-inducing factor (AIF) within mitochondria [24,
25]. The large subunit of calpain 1 contains a mitochondrial leader se-
quence in its N-terminus [27]. The small subunit of calpain 1 (calpain
4) can be imported intomitochondriawith the corresponding large sub-
unit [27]. The biochemical characteristics of mitochondrial calpain 1 are
similar to cytosolic calpain 1 with an 80 kDa large catalytic subunit as
well as a 28 kDa regulatory small subunit-calpain 4 [4]. Mitochondrial
calpain 1 was initially localized within the mitochondrial intermem-
brane space in liver mitochondria [24]. Our previous study showed
that calpain 1 is also present in the intermembrane space. We also
Fig. 1.Depiction of the domain structure of typical and atypical calpains. Compared to the typical calpains, the atypical calpains lack the Penta-EF hand in their domain IV. Calpain 4 only can
bind with the typical calpains that contain the Penta-EF hand in their domain IV area.
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cluding inner membrane and matrix in cardiac mitochondria [25].
In order to further localize calpain 1 (CPN1) within cardiac mito-
chondria, mitochondrial components were separated using mitochon-
dria isolated from pooled mouse hearts (see protocol in Fig. 2). The
large subunit of CPN1 (mit-CPN1, arrow pointed in Fig. 3) was found
in mitochondria, crude outer membrane (c-OMM), intermembrane
space (IMS), and matrix (MTR). Human calpain 1 (HCPN1) was used
as a positive control to show that the top band was the mit-calpain 1,
whereas the low and thick bandwas a non-speciﬁc band (Supplemental
Fig. 1). Themit-CPN1was not found in the puriﬁed OMM (p-OMM), in-
dicating that the mit-CPN1 was loosely attached on the OMM or con-
taminated by cytosolic CPN1. The mit-CPN1 was not detected in both
crude inner membrane (c-IMM) nor puriﬁed inner membrane (p-
IMM), indicating that the mit-CPN1 was not an IMM protein (Fig. 3).
Calpain 4 was found in mitochondria, IMS, and MTR corresponding, as
expected to mit-CPN1 and conﬁrming localization. Calpastatin was de-
tected in mitochondria, c-OMM, IMS, c-IMM, and MTR, again present
at least in compartments where mit-CPN1 exists. Calpastatin was not
detected in p-OMM and p-IMM, indicating that calpastatin was loosely
attached and a potential contamination from cytosol (c-OMM) or ma-
trix (c-IMM). VDAC (voltage dependent anion channel) was used as
anOMMmarker. VDACwas detected in both OMMand IMM, consistent
with the notion of contact sites where OMM and IMM merge [28,29].
Subunit α of complex V was used as an inner membrane marker. Com-
plex V was found in the c-OMM but not in the p-OMM, indicating thatFig. 2. Depiction of procedures to separate mitochondrial components. Brieﬂy, mitochondria w
the outer mitochondrial membrane (OMM). After digitonin treatment, supernatant including
membrane) and MTR (matrix) by centrifugation. The ultra-centrifuge was used to separate O
separated by ultra-centrifugation. The OMM and IMM were puriﬁed by linearization. Ultra-cen
immunoblotting.the puriﬁcation procedure removed potential contamination of the
IMM from the OMM. Complex V was detected in both the c-IMM and
the p-IMM. Cytochrome c [30] and PDH [31] were used as markers of
the IMS and MTR, respectively. Cytochrome c was mainly present in
the IMS, whereas pyruvate dehydrogenase (PDH) was mainly found in
the MTR. However, some cytochrome c was detected in the c-OMM,
and PDH was also found in the c-IMM. Thus, these results indicate that
proper puriﬁcation is critical to locate the mitochondrial proteins in
the corresponding compartment.
In livermitochondria, calpain 2 is also found in the IMS [26]. Activation
of mitochondrial calpain 2 increases the permeability of the OMM by
interacting with VDAC in liver mitochondria [26]. Calpain 2 is also identi-
ﬁed in brain mitochondria isolated from the hippocampus, cerebellum,
and cortex [32]. However, calpain 2 is barely detected in the trypsin-
puriﬁed heart mitochondria [25]. These results indicate that calpain 2 is
less likely to be located in the IMS and theMTR in heartmitochondria. Re-
cently, calpain 2 has been detected in non-protease puriﬁed rat heart mi-
tochondria and localized to the mitochondrial matrix [33]. Therefore,
Percoll puriﬁcation, rather than trypsin treatment, may need to be used
to test if calpain 2 truly exists in mouse heart mitochondria. Similarly,
evaluation of calpain 2 content in protease-puriﬁed intact rat mitochon-
dria would exclude non-speciﬁc adsorption of calpain 2 to mitochondria
in that model. Currently, calpains 1 and 2 are identiﬁed in mitochondria
based on immunoblotting results. Calpain antibodies for different do-
mains may generate variable results [24]. Therefore, a genetic approach
may be needed to clarify the issue. Calpain 1 speciﬁc knockout mice areere isolated from pooled mouse hearts. Digitonin was used to permeabilize and rupture
OMM and IMS (intermembrane space) was separated from pellet including IMM (inner
MM from IMS. Sonication was used to permeabilize the IMM. The IMM and MTR were
trifuge was used to pellet the puriﬁed OMM and IMM. These components were used for
Fig. 3. Localization ofmitochondrial calpain 1 (mit-CPN1) in differentmitochondrial components isolated frompooledmouse hearts. Themit-CPN1 band (top band, over 75 kDa)was very
close to a non-speciﬁc band (under 75 kDa) [24]. The mit-CPN1 was detected in mitochondria, crude OMM (c-OMM), the IMS, and the MTR. The mit-CPN1 was removed in the puriﬁed
OMM (p-OMM), suggesting that themit-CPN1was loosely attached on the crude OMM. Themit-CPN1 on the c-OMMmay come from the IMS because some cytochrome cwas also found
on the c-OMM. Calpain 4 (small subunit of calpain 1) was localized to mitochondria, the IMS, and the MTR. Calpastatin was found in mitochondria, the c-OMM, the IMS, c-IMM (crude
IMM), and the MTR. Calpastatin was not detected in the p-OMM and p-IMM (puriﬁed IMM), suggesting that calpastatin detected in the c-OMM and c-IMM was contaminating from
the IMS and the MTR. VDAC (voltage dependent anion channel), cytochrome c (Cyt c), complex V, and PDH (pyruvate dehydrogenase) were used as the marker of the OMM, the IMS,
the IMM, and theMTR, respectively. Some Cyt c and PDHwere detected in the c-OMMand the c-IMM, indicating that proper puriﬁcation is critical to separate mitochondrial components.
VDAC was detected in the p-OMM and the p-IMM, indicating that contact size is present in these components.
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ment of conditional calpain 2 knockoutmice is needed to clarify if calpain
2 is located in mouse heart mitochondria.
Calpain 10 is another mitochondrial localized calpain involved in
calcium-induced mitochondrial dysfunction [35]. In renal cortex mito-
chondria, calpain 10 is found in outer membrane, intermembrane
space, inner membrane andmatrix [35]. Calpain 10 is present in cardiac
mitochondria [36]. Activation of calpain 10 increases cell injury by
impairing the mitochondrial respiratory chain [35] and is also involved
in the disruption of ryanodine receptor-mediated apoptosis [36]. There-
fore, activation of themit-CPN1 and calpain 10 each appears to contrib-
ute to cell injury during ischemia–reperfusion.Fig. 4. Depiction of the potential role of mit-CPN1 within mitochondria. Calcium enters into th
exchange located at the IMM. Calcium within the MTR is exported through Na+/Ca2+ exchan
of calcium from the MTR. The increased calcium concentration in cytosol during ischemia–re
REP or heart failure can increase mitochondrial calcium concentration through ER stress. M
the IMS. Activation of the mit-CPN1 within the MTR may damage the complex I through cle
MPTP opening through interaction with the cyclophilin D (CyD) and p53.2.1. Regulation of mitochondrial calpain activity
Calpains are calcium-dependent proteases and their activities are
regulated by intracellular calcium concentration [37]. Calcium is
imported into mitochondria mainly through the calcium uniporter
(H+/Ca2+) in the IMM [38,39]. Calcium is extruded from mitochondria
into cytosol through Na+/Ca2+ exchange [40,41] and MPTP opening
[42] (Fig. 4). Calpain 1 is activated in the presence of 3–50 μmol/L
Ca2+, whereas activation of calpain 2 requires high calcium concentra-
tions (400–800 μmol/L Ca2+) [24,43,44]. In the resting cardiacmyocyte,
the calcium concentrationwithin themitochondrialmatrix is estimated
to be approximately 100 nM, similar to the calcium concentration ine IMS through VDAC. Calcium within the IMS is imported into the MTR through H+/Ca2+
ger. Calcium overload within the MTR can trigger MPTP opening that leads to an outﬂow
perfusion (ISC–REP) or heart failure leads to calcium overload within mitochondria. ISC–
itochondrial calcium overload activates the mit-CPN1 that in turn cleaves AIF within
avage of subunits and degradation of PDH. Activation of the mit-CPN1 can facilitate the
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myocyte contraction [48]. Taken together, the calcium concentration
within the matrix is barely sufﬁcient to activate the mit-CPN1 under
physiologic conditions. In buffer-perfused heart, the calcium concentra-
tion in thematrix is around 250 nMduring equilibration perfusion [49].
Calcium concentration is increased to approximately 1 μM at the end of
25min ischemia and to 2.6 μMat the end of 30min reperfusion [49,50].
The calcium concentration in thematrix is still lower than the threshold
to activate the mit-CPN1 even at the peak calcium that occurs early in
reperfusion. These measured calcium concentrations would appear
even less likely to activate mitochondria-localized calpain 2. However,
the calcium threshold to activate calpain is dramatically decreased
during oxidative stress [51,52]. Ischemia–reperfusion damages the mi-
tochondrial respiratory chain and markedly increases the ROS genera-
tion [53–56]. Therefore, mit-CPN1 and possibly calpain 2 [33] can be
activated in the presence of mitochondrial calcium overload combined
with oxidative stress during ischemia–reperfusion.
Calcium overload also activates calpain 10, although some isoforms
of calpain 10 are not solely calcium-dependent [35]. As discussed
above, calpain 1 and calpain 2 belong to typical calpains, and their activ-
ity is regulated by calpain 4 (a small subunit of calpains 1 and 2) [4]. Ge-
netic ablation of calpain 4 completely eliminates the activities of calpain
1 and calpain 2, supporting that calpain 4 is necessary for the activation
of calpain 1 and calpain 2 [4,57,58]. Calpastatin is an endogenous inhib-
itor of typical calpains [1]. Calpain 4 and calpastatin have already been
identiﬁed within mitochondria [24] (Fig. 3). Thus, the CPN1 and CPN2
activities, including inmitochondria, can be regulated by genetic knock-
out of calpain 4 [58] or overexpression of calpastatin [59]. Calpain 10 is
an atypical calpain [6], and its activity is not subject to regulation by
calpain 4 and calpastatin. Themechanism to regulate calpain 10 activity
remains unclear, although post-translational modiﬁcation including
phosphorylation may affect calpain 10 activity [60]. In addition to en-
dogenous regulatorymechanisms, calpain activity is also affected in dif-
ferent physiological conditions. The activities of calpains are decreased
under acidic conditions [10,13,24,61], although sensitivity to acidiﬁca-
tion is different among calpains. In liver mitochondria, calpain 1 activity
is regulated through a chaperone protein ERp57 [10,13,24,26,61]. A
number of calpain inhibitors are available tomanipulate calpain activity
under pathophysiologic conditions [11,24,62]. MDL-28170 is a typical
calpain inhibitor that is used to inhibit calpain 1 and calpain 2 [11,24,
62]. Although PD150606 is a more selective calpain 1 inhibitor, it is
still not an exclusive CPN1 inhibitor [63]. A selective inhibitor of calpain
10 is also available [64].
3. Mitochondrial calpain 1 in intermembrane space
Calpains are involved in many pathophysiological processes includ-
ing embryonic development, cell function, intracellular signal transduc-
tion, cell cycle, and ischemia–reperfusion injury [2,3,65]. Many proteins
are substrates of cytosolic calpain 1 and calpain 2 [66]. Calpain cleaves
the cytoskeleton and membrane associated proteins including α2-
spectrin, which is used as a biological marker of calpain activation [10,
13,15,67]. Intracellular calcium overload during ischemia–reperfusion
activates cytosolic calpains 1 and 2 [10,11,13,15,67]. The activated
cytosolic calpains 1 and 2 in turn increase calcium overload by cleaving
calcium regulator proteins including Na+–K+-ATPases, Ca2+-ATPases,
H+-ATPases, Na+/H+-exchanger, and Na+/Ca2+-exchanger [10,15,68,
69]. Thus, calpain activation plays a critical role in the failure of intra-
cellular calcium control mechanisms that result in an excessive
intracellular calcium accumulation [2,3]. Intracellular calcium over-
load eventually leads to mitochondrial calcium overload that may
activate mitochondrial localized calpain 1 and possibly calpain 2
with the higher calcium requirement.
Activation of mit-CPN1 likely contributes to cardiac injury during is-
chemia–reperfusion [25,70]. A translocation of intermembrane space
proteins including cytochrome c, AIF, Smac/DIABLO, and Omi/HtrA2from mitochondria into cytosol and nucleus triggers apoptotic cell
death [20,21,65,71,72]. Loss of cytochrome c from mitochondria also
enhances necrotic cell death by reducing bioenergy production through
inhibition of oxidative phosphorylation [54,73–75]. Among these
intermembrane proteins, the relationship between activation of mit-
CPN1 and loss of AIF from mitochondria is well established [24,25].
Translocation of AIF from mitochondria to the nucleus triggers
caspase-independent cell death by inducing DNA damage [76–78]. The
mature form of AIF (62 kDa) is anchored at the inner mitochondrial
membrane within the intermembrane space [79]. In order to release
AIF from the mitochondria into cytosol, the mature AIF ﬁrst must be
detached from the inner membrane. In the isolated liver or heart mito-
chondria, incubation of mitochondria with exogenous calcium cleaves
themature AIF (62 kDa) to a truncated AIF peptide (about 57 kDa). Ad-
ministration of a calpain inhibitor prevents the calcium-mediated AIF
cleavage [24]. These results support that activation of mitochondrial
calpain leads to AIF cleavage. As discussed above, only the mit-CPN1 is
identiﬁed in the intermembrane space of cardiac mitochondria [25].
Therefore, activation of mit-CPN1 leads to AIF cleavage in heart mito-
chondria. However, it has been reported that mitochondrial calpain 1
is not involved in AIF cleavage in brain mitochondria [80]. Thus, the
link between mitochondrial activation of calpain 1 and AIF cleavage
may be tissue dependent.
Following detachment from the innermembrane, permeation of the
outermitochondrialmembrane is required for the release of cleaved AIF
from the intermembrane space [24]. In isolated livermitochondria, acti-
vation ofmitochondrial calpain 2 increases the permeability of the outer
mitochondrialmembrane by cleaving VDAC and inducing accumulation
of bax on the outer membrane [24]. Although calpain 2 has not been
identiﬁed in murine cardiac mitochondria [25], it has been identiﬁed
in rat heartmitochondria [33]. Ischemia–reperfusion is known to trigger
mitochondrial permeability transition pore (MPTP) opening that in turn
increases the outer membrane permeability [71]. In addition, ischemia
can increase the permeability of the outermembrane through induction
of imbalance between anti-apoptotic and pro-apoptotic bcl-2 family
proteins [81,82]. Taken together, a key step for AIF release from mito-
chondria into cytosol is to detach the AIF from the inner membrane
through activation of mit-CPN1.
4. Mitochondrial calpain 1 within the matrix
Administration of calpain inhibitors decreases cardiac injury during
ischemia–reperfusion [2,3]. In isolated rabbit hearts, inhibition of
calpain improves oxidative phosphorylation in cardiac mitochondria
following ischemia–reperfusion, supporting that the activation of
calpain contributes tomitochondrial energy generation [83,84]. In addi-
tion, calpain inhibition attenuates the increased state 4 respiration in
mitochondria following ischemia–reperfusion, indicating that activa-
tion of calpain increases the permeability of the inner mitochondrial
membrane [83]. In liver mitochondria, inhibition of calpain using Cbz-
Leu-Leu-Tyr-CHN2 delays the exogenous calcium-induced depolariza-
tion of mitochondrial inner membrane potential [85], suggesting that
activation of calpain triggers the MPTP opening.
The activity of mitochondrial calpain 1 is increased in cardiac mito-
chondria following ischemia–reperfusion [25]. The administration of a
calpain inhibitor during ischemia–reperfusion to the buffer perfused
heart improved oxidative phosphorylation using complex I substrates
[84]. Inhibition of calpain also decreased the MPTP opening in mito-
chondria isolated from mouse heart following ischemia–reperfusion
[84]. These results suggest that activation of mit-CPN1 contributes to
electron transport damage including complex I and MPTP opening
during ischemia–reperfusion. We propose that activation of calpain 1
within themitochondrialmatrix damages complex I by cleavage of sub-
units. In the rat heart, calpain 2 was localized to mitochondrial matrix,
with activity favoring MPTP and complex I damage via cleavage of sub-
units [33]. Thus, during ischemia and reperfusion, multiple studies are
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processes that damage mitochondrial metabolism and favor cell death.
Mitochondrial calpain 10 is localized within mitochondrial matrix
[35]. In renal mitochondria, activation of mitochondrial calpain 10 im-
pairs the electron transport chain by proteolytic digestion of complex I
subunits [35,86]. Genetic ablation of complex I subunits sensitizes to
the MPTP opening in mouse heart mitochondria [87]. Thus, the dam-
aged complex I not only can decrease the rate of respiration [20], but
it also may sensitize mitochondria to undergo MPTP opening which is
a keymechanism to induce cell death during ischemia–reperfusion [87].
In addition to damage to the ETC, ischemia–reperfusion impairs
metabolic enzymes in the tricarboxylic acid (TCA) cycle in cardiac mito-
chondria [88–90]. Proteomic studies show that ischemia–reperfusion
leads to degradation ofmetabolic enzymes includingpyruvate dehydro-
genase (PDH), malate dehydrogenase (MDH), and succinate dehydro-
genase (SDH) in rat heart mitochondria [88–90]. Our ongoing study
showed that ischemia–reperfusion led to decreased PDH content in
buffer perfused mouse heart [91]. Incubation of isolated mouse heart
mitochondria with exogenous calcium also decreased PDH, whereas in-
hibition of mit-CPN1 using MDL protected PDH content. These results
suggest that activation of the mit-CPN1 contributes to degradation of
PDH during ischemia–reperfusion, perhaps providing a mechanism for
the previously observed decrease in the matrix protein content during
ischemia–reperfusion.
Exogenous calcium treatment leads to depolarization of the inner
mitochondrial membrane potential in a dose-dependent manner in
isolated heart mitochondria. Inhibition of calpain using MDL-28170
attenuates the calcium-induced depolarization of the inner membrane
potential [84]. These results clearly show that activation of mit-CPN1
contributes to inner membrane permeability increases in heart
mitochondria. However, the mechanism by which activation of mito-
chondrial calpain 1 permeabilizes the inner membrane, and the poten-
tial role of MPTP, remains unclear.
Administration of a calpain inhibitor to the intact heart can decrease
MPTP opening through regulation of intracellular calcium status via
inhibition of cytosolic calpain [10,13,15]. As discussed above, activation
of cytosolic calpain during ischemia–reperfusion can increase intracel-
lular calcium concentration by cleaving Na+, K+-ATPase, Ca2+-ATPase,
H+/Na+ exchanger, and Na+/Ca2+ exchanger [2,3]. Activation of cyto-
solic calpain can increase the permeability of the outer mitochondrial
membrane through cleavage bid to t-bid [11]. Calpain 1 is also found
on the endoplasmic reticulum (ER) [92]. Therefore, calpain activation
can cause calcium overload through ER stress [93]. Taken together,
activation of cytosolic calpains can sensitize MPTP opening through in-
duction of intracellular calcium overload and subsequentmitochondrial
calcium overload.
The exact mechanism by which activation of the mitochondrial
calpains sensitizes the MPTP opening in cardiac mitochondria remains
unclear. p53 is a tumor suppressor protein and its content is normally
maintained at a low level by interaction with Mdm2 (mouse double
minute 2 homolog) that leads to degradation [94]. The p53 content rap-
idly increases in cytosol and nucleus during oxidative stress through
phosphorylation and subsequent dissociation from Mdm2 [95]. The
phosphorylated p53 is transferred to and accumulates within mito-
chondria to increase MPTP opening through formation of a complex
with cyclophilin D [94,96]. Calpain plays a critical role in maintaining
p53 level within cells [97]. Activation of cytosolic calpain facilitates the
translocation of p53 from cytosol to brain mitochondria [98], indicating
that cytosolic calpain activation may induce MPTP opening through fa-
cilitation of p53 translocation from cytosol to mitochondria (Fig. 4). Ac-
tivation of mitochondria-localized calpain 1 [84] or calpain 2 [33] may
sensitize the MPTP opening in cardiac mitochondria by impairing com-
plex I [33,84]. Cyclophilin D is a critical regulator of the MPTP opening
[99]. Cyclophilin D is located within the matrix and can be accessed by
the mit-CPN1. Genetic inhibition of complex I sensitizes MPTP opening
in heart mitochondria through increased protein acetylation [87].Administration of calpain inhibitor attenuates complex I damage and
decreases MPTP opening in heart mitochondria following ischemia–re-
perfusion [33,84], suggesting that activation of mit-CPN1 sensitizes
MPTP opening by impairing complex I. Taken together, activation of
mit-CPN1 may increase MPTP opening by facilitating translocation of
cyclophilin D from the matrix to the inner mitochondrial membrane
through interaction with p53 [97] or by impairing complex I in the
respiratory chain [87].
Since there is no exclusive mit-CPN1 inhibitor available, pharmaco-
logical approaches are not sufﬁcient to clarify the role of mitochondrial
calpains in cardiac injury during ischemia–reperfusion. Genetic ap-
proaches are already used to manipulate calpain 1 and 2 activities. Al-
though calpain 4 [4] or calpain 1 [34] knockout mice are available, and
would distinguish the roles of calpains 1 and 2 in the mitochondria,
these mice also have limitations in that global knockout of calpain 4 or
calpain 1 affects both cytosolic and mitochondrial calpain activities.
Therefore, selective overexpression of calpain 1 within mitochondria
or development of a calpain inhibitor targeted into mitochondria
could be a proper approach to investigate the role of mit-CPN1 activa-
tion in cardiac injury.
5. Other proteases within mitochondria
In addition to calpains, other proteases exist within mitochondria.
Lon and Clp (caseinolytic protease) are proteases located within the
mitochondrial matrix. The detailed role of Lon and Clp in maintaining
mitochondrial protein integrity can be found in a recent excellent re-
view [100]. Brieﬂy, the critical role of the Lon protease is to remove
the oxidized protein within mitochondrial matrix, whereas the Clp pro-
tease plays a key role inmitochondrial unfolded protein response [100].
In renal proximal tubular cells, oxidative stress leads to the degradation
of calpain 10. Administration of Lon inhibitor decreases the calpain 10
degradation [101]. These results indicate that there is an interaction
between Lon and mitochondrial calpain 10. These two proteases likely
contribute a critical role in degradation of the damaged mitochondrial
proteins, especially in stressed conditions.
6. Summary and conclusions
Although more than one calpain family is located within mitochon-
dria, the focus of our current review is to identify the localization ofmit-
CPN1 and explore its potential function in cardiac mitochondria, espe-
cially during ischemia–reperfusion. Activation of mit-CPN1 within the
intermembrane space induces a release of AIF from mitochondria into
cytosol through cleavage of AIF to truncated AIF. In contrast, activation
of themit-CPN1 andmit-CPN2withinmitochondrialmatrix inhibitsmi-
tochondrial metabolism by damaging complex I subunits or degrading
metabolic enzymes. In addition, activation of the mit-CPN1 or mit-
CPN2may sensitize toMPTP opening in cardiacmitochondria following
ischemia–reperfusion. Inhibition of cytosolic calpains decreases cardiac
injury during ischemia–reperfusion. Modulation of mitochondrial local-
ized calpain, especiallymit-CPN1, may provide a complimentary, prom-
ising strategy to decrease cardiac injury during ischemia–reperfusion.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbadis.2015.08.004.
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Mit-CPN1 mitochondrial calpain 1
ETC mitochondrial electron transport chain
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ROS reactive oxygen species
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PDH pyruvate dehydrogenase
MDH malate dehydrogenase
Mdm2 mouse double minute 2 homolog
SDH succinate dehydrogenase
VDAC voltage dependent anion channel
TMRM tetramethylrhodamine
CyD cyclophilin D
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